Stocks to buy

The plant-based prescription medicine developer Jaguar Health (NASDAQ:JAGX) is one of the more unique biopharmaceutical companies on the market today. So JAGX stock isn’t for folks who value safety above all else, because Jaguar health isn’t your typical drugmaker. Source: luchschenF / Shutterstock.com Perhaps Jaguar Health’s most notable product is Mytesi (crofelemer), which is “the only
0 Comments
Solar stocks have been popping recently and for good reason. According to the International Energy Agency, in the next 10 years solar output will create a surge in the renewable power supply. A report by Wood Mackenzie also estimates that solar energy will become the cheapest form of U.S. power by fiscal year 2030. Given
0 Comments
Semiconductor stocks saw massive capital inflows last week as many jumped to record highs. With fresh strength taking the industry, now is a perfect time to hunt for opportunities. While some constituents have run beyond low-risk entry points, others still sit at attractive buy areas. We’ve seen increased attention on the worldwide shortage of chips.
0 Comments
It’s common knowledge that investing in undervalued stocks can generate some juicy returns over the long haul. However, the tricky part is investing in the right stocks at the right time. Investors often favor certain sectors over others and undervalued stocks tend to be in the latter category. Although 2021 is shaping up to be
0 Comments
Walt Disney (NYSE:DIS) — a company that has become bifurcated amid the pandemic with a surging streaming business and a stumbling parks business — reported first-quarter numbers in mid-February that didn’t surprise anyone. Over the past three months, Disney’s streaming services Disney+, ESPN+ and Hulu grew like clockwork. Disneyland and Disney World parks, though, continued to
0 Comments
As I’m preparing my latest article about Nio (NYSE:NIO), the hard-charging Chinese manufacturer of electric vehicles (EVs), Nio stock trades for $60. That values the company at $93.6 billion, good for the fifth spot amongst the world’s largest automakers by market capitalization.  Source: Sundry Photography / Shutterstock.com On Feb. 1o, Deutsche Bank analyst Edison Yu
0 Comments
Payments platform PayPal (NASDAQ:PYPL) has been one of Wall Street’s biggest winners for years. Over the past five years, PYPL stock is up nearly 800%. Why? Because PayPal has emerged as a winner in the Digital Revolution, wherein consumers are shifting all their activity into the digital world. Source: JHVEPhoto / Shutterstock.com That’s the good
0 Comments
If you had asked me my opinions about where the market was heading following the initiate strike of the novel coronavirus, I wouldn’t have guessed what we’re seeing now. Extreme bullishness has entered the collective sentiment, sending some companies to ridiculous valuations. But is there any more room left for genuinely cheap stocks? You’d be
0 Comments
Fidelity Investments’ history goes back to the early 1940s. Many investors associate mutual funds with Fidelity. However, in recent years, the company has increased its exchange-traded funds. Therefore today, we’ll introduce seven Fidelity index funds that can help diversify your long-term portfolio. Lucian Bebchuk and Scott Hirst of the National Bureau of Economic Research in
0 Comments
Last week, social media company Snap (NYSE:SNAP) reported strong fourth-quarter numbers which beat the Street’s expectations on all fronts. Users, revenues and profits all topped the analysts’ consensus estimates. In response, SNAP stock popped to fresh all-time highs. Source: dennizn / Shutterstock.com Since then, SNAP stock has retreated on news that the company is filing
0 Comments
The key to scoring huge gains in the stock market rests in identifying innovative hypergrowth companies in the top of the first inning of their growth narratives. And, with that in mind, I’d like to introduce readers to space technology pioneer Momentus — who, through a merger with blank-check company Stable Road Acquisition Corp (NASDAQ:SRAC),
0 Comments
The pandemic served as a tailwind for Facebook (NASDAQ:FB) and the gains were reflected in the company’s blowout fourth-quarter earnings. But despite the results, Facebook stock is up just a little over 20% for the year and underperformed Nasdaq’s 45% spike. Source: fyv6561 / Shutterstock.com The weak rally can be attributed to “significant uncertainty” in its future
0 Comments
In the last year, pharmaceutical stocks, in general, have taken a back seat to coronavirus vaccine makers. Seemingly, unless it was tackling Covid-19, a drug maker was viewed by stock market traders as dull. When the market prices future earnings, they bid up shares of BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA). Those stocks rose by two-fold and
0 Comments